EP267/#913 Monitoring of minimal residual disease with circulating tumor DNA in patients with epithelial ovarian cancer on long-term PARP inhibitor maintenance therapy
EP267/#913 Monitoring of minimal residual disease with circulating tumor DNA in patients with epithelial ovarian cancer on long-term PARP inhibitor maintenance therapy